The Valley Desk

Clinical trial reportClinical pharmacology and therapeuticsPublished

Mechanistic Population Pharmacokinetic-Pharmacodynamic Model of the Tau-Targeted Antibody Posdinemab in Healthy Participants and Participants with Alzheimer's Disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical pharmacology and therapeutics
Published
Subject terms
Humans; Alzheimer Disease; tau Proteins; Dose-Response Relationship, Drug; Models, Biological; Adult; Aged; Aged, 80 and over; Middle Aged; Female; Male; Young Adult
PubMed ID
41431125
Added to directory
Source checked

Report a correction or request removal